{"url":"https://lda.senate.gov/api/v1/filings/564497fe-374e-42e6-ac90-4adcd1143e7d/?format=json","filing_uuid":"564497fe-374e-42e6-ac90-4adcd1143e7d","filing_type":"Q4","filing_type_display":"4th Quarter - Report","filing_year":2018,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/564497fe-374e-42e6-ac90-4adcd1143e7d/print/","filing_document_content_type":"text/html","income":null,"expenses":"26316.38","expenses_method":"c","expenses_method_display":"Method C - Reporting amounts under section 162(e) of the Internal Revenue Code","posted_by_name":"E. Blair Clark-Schoeb","dt_posted":"2019-01-18T13:10:58.143000-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"600 LEE ROAD SUITE 100","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"WAYNE","registrant_state":"PA","registrant_zip":"19087","registrant":{"id":401104361,"url":"https://lda.senate.gov/api/v1/registrants/401104361/?format=json","house_registrant_id":43561,"name":"ZYLA LIFE SCIENCES (FKA EGALET CORPORATION)","description":"Specialty Pharmaceutical Company","address_1":"600 LEE ROAD SUITE 100","address_2":null,"address_3":null,"address_4":null,"city":"WAYNE","state":"PA","state_display":"Pennsylvania","zip":"19087","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MADELINE SCHERWITZKY","contact_telephone":"+1 425-523-8565","dt_updated":"2022-04-06T16:06:32.276341-04:00"},"client":{"id":201602,"url":"https://lda.senate.gov/api/v1/clients/201602/?format=json","client_id":12,"name":"ZYLA LIFE SCIENCES (FKA EGALET CORPORATION)","general_description":"Registrant's name change from Egalet Corporation to Zyla Life Sciences","client_government_entity":false,"client_self_select":true,"state":"PA","state_display":"Pennsylvania","country":"US","country_display":"United States of America","ppb_state":"PA","ppb_state_display":"Pennsylvania","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2017-02-20"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Pain therapy access policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":72598,"prefix":null,"prefix_display":null,"first_name":"EILEEN BLAIR","nickname":null,"middle_name":null,"last_name":"CLARK-SCHOEB","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"ALC","general_issue_code_display":"Alcohol and Drug Abuse","description":"None","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":72598,"prefix":null,"prefix_display":null,"first_name":"EILEEN BLAIR","nickname":null,"middle_name":null,"last_name":"CLARK-SCHOEB","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Prescription drug abuse and misuse policy issues\nPain therapy access policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":72598,"prefix":null,"prefix_display":null,"first_name":"EILEEN BLAIR","nickname":null,"middle_name":null,"last_name":"CLARK-SCHOEB","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}